Gracell Biotechnologies
GRCL
#5534
Rank
A$1.56 B
Marketcap
$16.20
Share price
0.00%
Change (1 day)
184.35%
Change (1 year)

Gracell Biotechnologies (GRCL) - Cash on Hand

Cash on Hand as of September 2023 : A$0.37 Billion

According to Gracell Biotechnologies's latest financial reports the company has A$0.37 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Gracell Biotechnologies - Cash on Hand chart (from 2019 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$0.31 B-21.68%
2021-12-31A$0.39 B157.36%
2020-12-31A$0.15 B138.39%
2019-12-31A$64.66 M175.07%
2018-12-31A$23.5 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.40 B 7.36%๐Ÿ‡บ๐Ÿ‡ธ USA